Ofatumumab (anti-CD20) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to MS4A1, >95%, high purity, Human IgG1, BINDING AGENT of B-lymphocyte antigen CD20 binding agent
Ofatumumab (anti-CD20) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to MS4A1, >95%, high purity, Human IgG1, BINDING AGENT of B-lymphocyte antigen CD20 binding agent
Ofatumumab (anti-CD20) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to MS4A1, >95%, high purity, Human IgG1
BINDING AGENT of B-lymphocyte antigen CD20 binding agent
Product Description
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg
Product Properties
Antibody Type
Primary antibody
Clonality
Recombinant
Isotype
Human IgG1
Light Chain Type
kappa
SDS-PAGE
26.7 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 180.0 kDa, under non-reducing conditions.
Purification Method
Protein A purified
Purity
>95%
Source
CHO supernatant
Form
Liquid
Concentration
Lot by Lot
Storage Temp
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS
679818-59-8
Images
Ofatumumab (anti-CD20) (Ab170277) - Flow Cytometry Flow Cytometry analysis of Raji cells labelling CD20 (red) with Ofatumumab (anti-CD20) (Ab170277). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Ofatumumab (anti-CD20) (Ab170277) - SEC The purity of Ofatumumab (anti-CD20) (Ab170277) is more than 95% verified by HPLC.